Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lucie Pfeiferová"'
Autor:
Ľudmila Křížová, Markéta Šafaříková, Marta Kalousová, Lucie Pfeiferová, Aleš Antonín Kuběna, Michal Vočka, Jan Ulrych, Věra Franková, Luboš Petruželka, Tomáš Zima, David Feltl
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Immunotherapy has dramatically influenced and changed therapeutical approach in non-small cell lung cancer (NSCLC) in recent five years. Even though we can reach long-term response to this treatment in approximately 20% of patients with NSCLC, we are
Externí odkaz:
https://doaj.org/article/186967b95f7d488e8f9646b9a2e8fc9e
Autor:
Jakub Červenka, Jiřina Tylečková, Helena Kupcová Skalníková, Kateřina Vodičková Kepková, Ievgeniia Poliakh, Ivona Valeková, Lucie Pfeiferová, Michal Kolář, Michaela Vaškovičová, Tereza Pánková, Petr Vodička
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 14 (2021)
Cell therapies represent a promising approach to slow down the progression of currently untreatable neurodegenerative diseases (e.g., Alzheimer's and Parkinson's disease or amyotrophic lateral sclerosis), as well as to support the reconstruction of f
Externí odkaz:
https://doaj.org/article/d1bb9a3dcc2e40f0a9e3e6cba493de5e
Autor:
Erik Vlcak, Jana Šáchová, Jiří Novotný, Jan Brábek, Petr Přikryl, Daniel Rösel, Miluše Hradilová, Lucie Pfeiferová, Barbora Dvořánková, Jana Frýdlová, Martin Vokurka, Lukáš Lacina, Michal Kolář, Karolína Strnadová, Karel Smetana, Jana Šmigová
Publikováno v:
Histochemistry and Cell Biology. 157:153-172
The incidence of cutaneous malignant melanoma is increasing worldwide. While the treatment of initial stages of the disease is simple, the advanced disease frequently remains fatal despite novel therapeutic options . This requires identification of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32725066e92cb915b292aa49d36e4761
https://doi.org/10.1007/s00418-021-02052-2
https://doi.org/10.1007/s00418-021-02052-2
Autor:
Jiří Švec, Monika Šťastná, Lucie Janečková, Dušan Hrčkulák, Martina Vojtěchová, Jakub Onhajzer, Vítězslav Kříž, Kateřina Galušková, Eva Šloncová, Jan Kubovčiak, Lucie Pfeiferová, Jan Hrudka, Radoslav Matěj, Petr Waldauf, Lukáš Havlůj, Michal Kolář, Vladimír Kořínek
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4137
Trophoblastic cell surface antigen 2 (TROP2) is a membrane glycoprotein overexpressed in many solid tumors with poor prognosis, including intestinal neoplasms. In our study, we show that TROP2 is expressed in preneoplastic lesions and its expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2593464efdbdfaffcb270bc1fb339bd
https://doi.org/10.1101/2022.07.27.501720
https://doi.org/10.1101/2022.07.27.501720
Autor:
Václav Mandys, Alexey Popov, Robert Gürlich, Jan Havránek, Lucie Pfeiferová, Michal Kolář, Jana Vránová, Karel Smetana, Lukáš Lacina, Pavol Szabo
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 3617
Volume 24
Issue 4
Pages: 3617
Therapy for pancreatic ductal adenocarcinoma remains challenging, and the chances of a complete cure are very limited. As in other types of cancer, the expression and role of miRNAs in controlling the biological properties of this type of tumor have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d67015f024aa9f52d75848b55edc46c
https://doi.org/10.3390/ijms24043617
https://doi.org/10.3390/ijms24043617
Autor:
Petr Vodicka, Tereza Pánková, Lucie Pfeiferová, Katerina Vodickova Kepkova, Jiřina Tylečková, Ievgeniia Poliakh, Jakub Cervenka, Helena Kupcova Skalnikova, Ivona Valekova, Michal Kolář, Michaela Vaškovičová
Publikováno v:
Frontiers in Cellular Neuroscience
Frontiers in Cellular Neuroscience, Vol 14 (2021)
Frontiers in Cellular Neuroscience, Vol 14 (2021)
Cell therapies represent a promising approach to slow down the progression of currently untreatable neurodegenerative diseases (e.g., Alzheimer's and Parkinson's disease or amyotrophic lateral sclerosis), as well as to support the reconstruction of f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b5a6f01482979ce55ac0c2ec11f4ca
https://pubmed.ncbi.nlm.nih.gov/33584205
https://pubmed.ncbi.nlm.nih.gov/33584205
Autor:
Veronika Obsilova, Kristýna Boušová, Jiří Vondrášek, Lucie Pfeiferová, Lucie Bednárová, Palani Kirubakaran
Publikováno v:
Proteins: Structure, Function, and Bioinformatics. 84:1358-1374
Artificial multidomain proteins with enhanced structural and functional properties can be utilized in a broad spectrum of applications. The design of chimeric fusion proteins utilizing protein domains or one-domain miniproteins as building blocks is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7641d89d2709322d69c1801e6e03eebb
https://doi.org/10.1002/prot.25082
https://doi.org/10.1002/prot.25082
Autor:
Palani, Kirubakaran, Lucie, Pfeiferová, Kristýna, Boušová, Lucie, Bednarova, Veronika, Obšilová, Jiří, Vondrášek
Publikováno v:
Proteins. 84(10)
Artificial multidomain proteins with enhanced structural and functional properties can be utilized in a broad spectrum of applications. The design of chimeric fusion proteins utilizing protein domains or one-domain miniproteins as building blocks is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef75bce623178bcc3c4bdb54c40a1344
https://pubmed.ncbi.nlm.nih.gov/27273513
https://pubmed.ncbi.nlm.nih.gov/27273513
Publikováno v:
Biophysical Journal. 110(3)
Synthetic fusion proteins of two or multiple domains using recombinant DNA technology are recently emerging in the field of protein engineering. The functional properties of the designed proteins were already enhanced and utilized for wide variety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12ad3f038172a14beb183c1770c9fbe0